Keywords: long-term, efficacy, merck, co, proscar, four-year, study

Long-Term Efficacy With Merck & Co's Proscar

Article | 05 March 1998

Print This

A four-year study of Merck & Co's 5-alpha-reductase inhibitor Proscar(finasteride 5mg) has shown that the drug reduced the need for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in